Finance

Lists
Why is 4155 up 9.48%?
Dive Deeper
4155:TPE
OK Biotech Co Ltd
NT$17.90
+9.48%
(+1.55) 1D
Nov 6, 1:30:05 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4155...
Open
NT$15.65
High
NT$17.90
Low
NT$15.25
Mkt. cap
2.24B
Avg. vol.
610.26K
Volume
1.49M
Dividend
1.68%
Quarterly dividend
NT$0.08
Ex-dividend date
Oct 20, 2026
P/E ratio
9.61
52-wk high
NT$18.41
52-wk low
NT$14.34
EPS
NT$1.86
Shares outstanding
74.63M
No. of employees
62
Open
NT$15.65
High
NT$17.90
Low
NT$15.25
Mkt. cap
2.24B
Avg. vol.
610.26K
Volume
1.49M
Dividend
1.68%
Quarterly dividend
NT$0.08
Ex-dividend date
Oct 20, 2026
P/E ratio
9.61
52-wk high
NT$18.41
52-wk low
NT$14.34
EPS
NT$1.86
Shares outstanding
74.63M
No. of employees
62
News stories
From web sources and news partners
About OK Biotech Co Ltd
CEOJames Lai
Employees62
Founded2004
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteokbiotech.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
379.58M
337.58M
383.78M
436.13M
Cost of goods sold
247.12M
244.34M
261.14M
305.92M
Cost of revenue
247.12M
244.34M
261.14M
305.92M
Research and development expenses
9.66M
22.76M
8.89M
15.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71.13M
50.12M
60.12M
71.50M
Operating expense
80.53M
36.72M
62.54M
78.54M
Total operating expenses
327.65M
281.06M
323.68M
384.46M
Operating income
51.94M
56.52M
60.10M
51.67M
Other non operating income
2.50M
-1.93M
4.69M
10.59M
EBT including unusual items
84.84M
69.51M
74.75M
64.00M
EBT excluding unusual items
83.43M
70.99M
75.71M
62.76M
Income tax expense
-1.54M
10.36M
11.18M
14.94M
Effective tax rate
-1.82%
14.91%
14.96%
23.35%
Other operating expenses
-
-
-
-
Net income
85.19M
53.54M
55.35M
48.16M
Net profit margin
22.44%
15.86%
14.42%
11.04%
Earnings per share
-
-
-
-
Interest and investment income
369.00K
1.01M
322.00K
2.02M
Interest expense
-2.62M
-3.65M
-1.83M
-1.76M
Net interest expenses
-2.25M
-2.64M
-1.51M
262.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
71.84M
76.42M
80.17M
71.72M
Gain or loss from assets sale
43.00K
294.00K
2.00M
6.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps